Monthly Archives: November 2026

Eye Drops Third-Party Manufacturing Guide

Eye Drops Third Party Manufacturing in India: What It Costs and What the Loan License Covers

Browse any B2B directory for contract eye drops and you will see asking prices from about ₹40 to ₹185 a bottle, sometimes for similar strengths. That spread is the first thing to understand about eye drops third party manufacturing in India. A licensed plant makes the product and your company puts its name on the carton. The price you pay depends less on the bottle than on the molecule and the license behind it.

If you don’t own a factory, there are two legal routes. The manufacturer can produce under its own license, or you can apply for a loan license and make your products at its plant under your name. Both are covered below, along with the sterility checks that matter far more for ophthalmic products than for tablets.

How the arrangement works

The brand owner handles marketing and distribution. The plant handles filling and batch testing, then ships. Novalab Eyevision’s third party manufacturing service lists four stages: product selection, packaging and branding, manufacturing support, and order and delivery coordination. It pitches the model at pharma companies, marketers and healthcare businesses that want an ophthalmic range without building a plant.

The law has no neat label for this. The law firm King Stubb & Kasiva points out that the Drugs and Cosmetics Rules, 1945 contain no express provision for contract manufacturing, so deals run on the license types the Rules do define.

You will also see “ophthalmic contract manufacturing” used for the same service. One Himachal manufacturer draws a line between the two: with contract manufacturing you bring your own formula, with third party you pick from the plant’s range. Third party suits you if you have prescribers who trust your name and no capital for cleanrooms. Contract manufacturing suits you once you have a formula worth protecting.

Loan license or the manufacturer’s license?

A loan license lets a company without its own factory make drugs at another licensed manufacturer’s premises. Goa’s drug regulator describes it in a licensing guide that also says the loan licensee needs a wholesale license. Applications go to the state drug control department, and the governing text is Rule 75A of the Drugs Rules, 1945.

Labelling is where this goes wrong in practice. The same law firm cites a court case where drugs were made in breach of loan license terms and labelled in breach of Rules 96 and 97. Whose name goes on the carton, and in what form, is a legal question and not a design one.

Under the other route, the manufacturer’s own license covers production. Pushkar Pharma’s guide adds a catch: if you use the plant’s formulations, you do not own them. That sounds minor until you want to move your best seller to a cheaper plant and find the formula stayed behind.

If you plan to build a brand around a few molecules over several years, raise the loan license at the first call. It adds an application to the state authority, but it gives you a document in your own name when questions arrive.

Rules and fees vary by state, so confirm the current procedure with your state drug control office or a regulatory consultant before signing anything.

What eye drops manufacturing cost actually depends on

Directory listings give a rough picture of third party eye drops pricing, and only a rough one. A supplier on TradeIndia asks ₹95 for 5 ml olopatadine 0.1% drops, with a minimum order of 500 pieces, and ₹105 and ₹130 for two of its other products. A Kindcare listing asks ₹180 for a 15 ml carboxymethylcellulose 0.5% bottle at the same 500 minimum. Another supplier lists 10 ml ofloxacin at ₹40 and a 5 ml ofloxacin and dexamethasone combination at ₹185, on a separate IndiaMART page.

Eye drops manufacturing cost swings with the molecule more than anything else. One Mohali exporters page shows a basic eye drop at ₹30 to ₹40 a piece and a bimatoprost drop at ₹738.37. It also lists a 5,000 bottle minimum for a bromfenac drop, ten times the 500 bottle floor above. At an illustrative ₹100 a bottle, that is the difference between ₹50,000 and ₹5 lakh of stock.

The bottle itself is cheap. A plain plastic dropper bottle can cost ₹1.50 at 5,000 pieces. What you pay for is the cleanroom filling and the testing behind every batch.

Compare quotes by what each one leaves out. Ask whether the carton, leaflet, artwork changes, stability data and GST sit inside the price. A quote that is ₹15 lower and excludes those is the more expensive quote.

None of these listings says what is included, and a directory price is an invitation to call, not a quote. If you would rather see a finished range before commissioning custom work, start with the eye drops range.

The part a quote won’t show: sterility

In 2023 the CDC linked an outbreak of extensively drug-resistant Pseudomonas aeruginosa to artificial tears sold as EzriCare and Delsam Pharma. The CDC notice says the manufacturer, Global Pharma of Chennai, recalled three products. Later reports counted three deaths and eight cases of blindness.

The FDA said the manufacturer had not done proper microbial testing and had skipped tamper-evident packaging. The company said early on it had not determined whether its own facility was the source. In eye drops third party manufacturing the same pattern holds: the brand names on the carton, and not the plant’s, appeared on the CDC notice.

Indian rules have tightened since. The health ministry set 31 December 2025 as the deadline for small and medium units to meet the revised Schedule M. Business Standard reported in December 2025 that only about 1,700 of an estimated 6,500 such units had submitted upgrade plans, and that roughly 2,000 already held WHO-GMP certification. So a plant’s Schedule M status is now a fair question to ask, and a fair one to ask in writing.

Eye drops also need aseptic filling in a Grade A/B cleanroom, according to Pushkar Pharma’s guide, so a plant that mostly makes tablets may not be set up for them. Novalab Eyevision’s quality policy names air handling units and HEPA filtration, plus per-batch testing of pH, osmolarity, viscosity and seal integrity. Whoever you choose, ask for the same level of detail.

Eye Drops Manufacturer in India

How to Choose the Best Eye Care PCD Company in India

In February 2023, the US Centers for Disease Control and Prevention issued a health advisory about a rare drug-resistant bacterial strain linked to preservative-free artificial tears. It counted 55 patients in 12 states, and the strain turned up in opened bottles of one brand. The manufacturer, a company in Chennai, later recalled three products.

Keep that story in mind while you look for the best eye care PCD company in India. You are about to attach your name, and every chemist and doctor relationship you’ve built, to a sterile liquid that goes into someone’s eye.

A thin margin can be fixed. A bad batch can’t. What follows is a PCD company checklist you can work through in about a week, starting at the factory and ending at your own desk.

Start at the factory, not the brochure

Plenty of PCD companies don’t run their own plant, and that’s legal. Contract manufacturing is a normal part of the industry (we offer third party manufacturing ourselves). The question is whether the company tells you which plant makes which product, at what address, under whose licence.

If the answer is vague, stop there.

India’s Good Manufacturing Practice rules changed recently, and the timeline is worth knowing. The revised Schedule M brought WHO-GMP standards into the law, and units with turnover above ₹250 crore had to comply from 28 June 2024.

Smaller units got extra time. In November 2025 CDSCO ordered the remaining 1,470 of them (out of 5,308 drug units nationally) to comply by 1 January 2026 with no further extensions.

On paper, that’s a hard deadline. In practice, a January 2026 report said an industry survey found about 25% of units still wanted an extension. So don’t assume any plant has made the jump. Ask for proof.

Three documents settle most of it:

  1. The manufacturing licence for the plant, showing it covers sterile ophthalmic products.
  2. The WHO-GMP certificate, with the issuing authority, the validity date and the product lines it covers. A certificate for a tablet block says nothing about the eye drop line.
  3. A certificate of analysis for the batch you’d actually be sold.

A WHO-GMP badge in a website footer isn’t a certificate. Ask for the file.

How to read a product list the way an ophthalmologist does

Eye doctors prescribe by condition: glaucoma, allergy, infection, dry eye, inflammation after surgery. A clinic stocks you if your range answers those, so check for gaps before you check for discounts.

Then look at how the company describes each product. The composition and strength should sit on the page next to the pack size. Novalab’s eye drop catalogue does this, with entries such as alcaftadine 0.25% in 5 ml and brimonidine 0.2% with timolol 0.5% in 5 ml. A name with no composition next to it is a red flag, because you can’t pitch what you can’t describe.

Watch for overlap too. Four brands of the same lubricant means your own territory competes against itself. And ask about shelf life after opening and whether preservative-free options come in single-dose packs, since the CDC outbreak involved multidose bottles.

Margin is the first number everyone asks about

Fair enough. But a 30% margin on stock that expires on your shelf is a loss with a good-looking invoice.

Get these answers in writing before you compare margins:

  • How much shelf life must remain when stock leaves their warehouse?
  • What happens to short-expiry or damaged stock?
  • Who pays freight, and what’s the minimum order quantity?
  • What are the payment terms on a first order versus a repeat one?

Territory deserves the same discipline. Many websites promise monopoly rights, and a sentence on a website is not a contract. The agreement should list the districts, the products covered, how long the rights last and what sales targets keep them alive. “Haryana” and “two districts of Haryana” are very different deals.

If you’re weighing a specific state, we’ve written separate guides on Haryana, Punjab and Himachal Pradesh.

Why a “top 10” list shouldn’t make the decision

Search for the best ophthalmic PCD company and read page one. Several results are written by companies that place themselves first. That’s marketing, and it’s fine as marketing, but it tells you nothing about who is actually best.

We publish a list of the top ophthalmic PCD companies too, and it says plainly that it’s an editorial shortlist, not an audited ranking. Use any list to build a shortlist of three. Then run the checks above on all three, ours included.

What an ophthalmic PCD pharma franchise really asks of you

It asks for patience. Eye care is prescription driven, so the doctor decides what sells, and a good range grows through repeat prescriptions on drops that patients use for months. Plan for a slow start.

A focused range suits a first-time partner for the same reason. Ten products you can explain to an ophthalmologist beat a hundred you can’t, and you’ll learn which doctors prescribe what much sooner. Budget for stock and working capital, but also for time: visits to eye clinics and eye hospitals, and the follow-up calls that actually turn a first order into a second one. If you want the broader picture of how we structure this, our PCD pharma franchise page explains the model.

Test the support before you need it

Send the same email to your three shortlisted companies on the same morning. Ask for the catalogue, the status of your territory and copies of the licences. Then watch who replies, how fast, and whether the answer is specific or a brochure.

Ask what promotional material comes with the franchise (visual aids and sample stock, for instance) and whether any of it costs extra. A company that answers slowly during the sales stage will not speed up after you’ve paid, and you’ll find out who your contact really is only when something goes wrong with an order.

Your own paperwork comes first

A distributor needs a wholesale drug licence (Forms 20B and 21B, issued by the State Licensing Authority) before dealing in drugs. Rules and documents vary by state, so confirm yours with your state drug control office. A company that is happy to ship to you without asking to see it is showing you how it runs everything else.

The PCD company checklist

Print this and fill it in for each company.

  1. Name and address of the plant that makes each product.
  2. Manufacturing licence covering sterile ophthalmic products.
  3. WHO-GMP certificate with issuer, validity and scope.
  4. Revised Schedule M compliance status, in writing.
  5. Composition and strength for every product, with pack size.
  6. Minimum remaining shelf life on dispatched stock.
  7. Written policy on expiry, damage and replacement.
  8. Districts, products and duration of your territory rights.
  9. Named contact who answers within a day.
  10. What promotional support is included and what costs extra.

How to score your three finalists

Give each checklist item 0 for no answer, 1 for a vague answer and 2 for a document or a written commitment. Add it up, but apply one rule before you add anything: a company that scores 0 on the first three items is out, whatever its margin looks like.

When you choose a PCD company, let paperwork break ties and leave the discount for last. A company that scores 17 with a 5% lower margin is the safer bet over two years than one that scores 9 and discounts hard, because you won’t be returning stock, rebuilding trust with a doctor or explaining a recall to a chemist.

Our guide to choosing an eye drops manufacturer goes deeper on the plant side if you want a second opinion on those first three items.

Frequently asked questions

What does PCD mean?
It stands for Propaganda Cum Distribution. The company supplies branded medicines, and you promote and distribute them in an agreed area.

Is a WHO-GMP certificate enough to call a company the best?
No. It shows a plant met a standard when it was inspected. You still need to check scope, validity, product range and the commercial terms.

Should I only pick a company that makes its own drops?
Not necessarily. A transparent contract manufacturer with current licences can beat an owner with a weak plant. What you can’t accept is a company that won’t say who makes the product.

How many companies should I compare?
Three is enough to see differences and few enough to check properly.

What to do this week

Send those ten checklist items to three companies and compare the replies by Friday. You’re welcome to start with us: the PCD franchise page explains how we work, and the contact page has our Panchkula address and phone numbers.

Eye Drops Manufacturing in India

How to Choose the Right Eye Drops Manufacturer in India for an Ophthalmic Pharma Franchise?

The demand for quality ophthalmic medicines has created business opportunities for pharmaceutical distributors, medical representatives, and entrepreneurs across India. Choosing a reliable Eye Drops Manufacturer in India can help you build an ophthalmic product portfolio, develop a distribution network, and enter the growing eye-care pharmaceutical market.

Businesses planning to enter this segment can explore an Ophthalmic PCD Pharma Franchise, third-party manufacturing, or an ophthalmic distribution model. The right manufacturing partner should have the required licences, quality control systems, a suitable product range, and clear business terms.

Why Should You Choose an Eye Drops Manufacturer in India?

An experienced eye drops manufacturer in India can supply ophthalmic formulations for distribution under an agreed business arrangement. Manufacturing quality, product documentation, packaging, pricing, and supply consistency directly affect your pharmaceutical business.

Eye drops require careful manufacturing because they are applied directly to the eyes. Sterility, microbial control, formulation quality, and suitable packaging need close attention throughout production.

Before selecting a manufacturer, check these factors:

  • Valid manufacturing licences and applicable product permissions.
  • Compliance with applicable Good Manufacturing Practices (GMP).
  • Quality testing and batch documentation.
  • Suitable packaging and product labelling.
  • Consistent product availability.
  • Clear pricing and distribution policies.

The Central Drugs Standard Control Organization (CDSCO) publishes India’s Drugs Rules, 1945, including specific requirements for sterile ophthalmic preparations. These requirements make manufacturing standards an essential part of supplier evaluation.

How to Start an Ophthalmic PCD Pharma Franchise in India?

Starting an ophthalmic PCD pharma franchise involves selecting a product portfolio, finding a suitable pharmaceutical company, completing business documentation, and developing a local distribution network.

Follow these 6 steps to get started:

1. Research your target market

Study the demand for ophthalmic medicines in your selected city or district. Speak with qualified eye-care professionals and understand which product categories are relevant to your distribution market.

2. Select an ophthalmic product range

Look for commonly prescribed product categories, such as lubricating eye drops, antibiotic formulations, anti-allergic preparations, and other ophthalmic products. Product selection should follow applicable approvals and prescription requirements.

3. Verify the pharmaceutical company

Check the manufacturer’s licences, manufacturing facilities, quality procedures, product permissions, and business history. Request relevant documents before placing an order.

4. Discuss franchise terms

Understand the minimum order quantity, product pricing, payment terms, promotional support, delivery arrangements, and territory availability.

5. Complete the required documentation

Discuss the applicable agreements, GST documentation, drug sale licences, and other regulatory requirements with the company and relevant state authorities.

6. Build your distribution network

Develop professional relationships with pharmacies, distributors, and eye-care clinics. Follow applicable rules for prescription medicines and pharmaceutical promotion.

A clear agreement and a carefully selected product range can make the initial investment easier to manage.

What Are the Benefits of an Ophthalmic Pharma Franchise with Monopoly Rights?

An Ophthalmic Pharma Franchise with Monopoly Rights gives a distributor exclusive marketing or distribution rights within an agreed geographical territory, subject to the terms of the contract.

This arrangement can help distributors plan their sales activities and develop a consistent customer base.

Common benefits include:

  • Territorial exclusivity: The company agrees to specific territory protection under the franchise contract.
  • Defined business terms: Pricing, payment conditions, and supply responsibilities can be documented.
  • Product portfolio access: Distributors can market multiple ophthalmic formulations from one company.
  • Marketing assistance: Promotional materials and product information may be provided, depending on the agreement.
  • Business planning: Territory protection can make local sales planning more predictable.

Before accepting monopoly rights, confirm the exact district or area covered, contract duration, renewal conditions, sales targets, and circumstances under which exclusivity can end.

Which Ophthalmic Products Should You Include in a Pharma Franchise?

A suitable ophthalmic product portfolio should address the requirements of your target market and the product categories permitted for distribution.

Some commonly marketed ophthalmic product categories include:

Product category Common purpose
Lubricating eye drops Relief from dry-eye symptoms
Anti-allergic eye drops Management of allergic eye conditions
Antibiotic eye drops Treatment of susceptible bacterial eye infections
Anti-inflammatory eye drops Management of certain inflammatory eye conditions
Combination eye drops Specific conditions where combination treatment is prescribed
Eye ointments Selected ophthalmic conditions requiring ointment formulations

Product availability, indications, and prescription requirements depend on the individual formulation and its approved labelling.

When selecting Ophthalmic Products for Pharma Franchise, examine product specifications, packaging sizes, shelf life, batch testing, and storage conditions. A broad product list is useful when each product has a clear market requirement and reliable supply.

How Does Third Party Manufacturing of Eye Drops Work?

Third Party Manufacturing of Eye Drops allows a pharmaceutical company or brand owner to get products manufactured through an appropriately licensed manufacturing facility under an agreed arrangement.

The manufacturing partner handles production according to the applicable regulatory requirements, while the contracting business manages its agreed branding, marketing, and distribution responsibilities.

The general process includes:

  1. Product selection: Finalise the formulations, strengths, and packaging requirements.
  2. Manufacturer verification: Check manufacturing licences, product permissions, and relevant quality certifications.
  3. Commercial discussion: Confirm manufacturing costs, minimum order quantities, payment conditions, and delivery timelines.
  4. Documentation: Complete the required manufacturing and commercial agreements.
  5. Production and testing: The manufacturer produces and tests the batch according to applicable specifications.
  6. Dispatch: Products are released and supplied with the required batch and product documentation.

For sterile eye drops, pay particular attention to aseptic manufacturing controls, environmental monitoring, sterilisation processes, and batch quality records.

CDSCO’s Drugs Rules include specific manufacturing requirements for sterile ophthalmic preparations. Reviewing these provisions can help businesses ask manufacturers more informed questions before finalising an arrangement.

How Can You Select the Right Ophthalmic Medicine Distributor in India?

An Ophthalmic Medicine Distributor in India needs reliable product availability, proper documentation, and a clear understanding of local pharmaceutical distribution requirements.

If you are appointing a distributor or evaluating a supplier, examine these points:

  • Does the company have the appropriate licences?
  • Can it provide product and batch documentation?
  • Are storage and transportation requirements clearly communicated?
  • Are prices and credit terms documented?
  • Is the distribution territory clearly defined?
  • Does the company have a process for handling complaints and product recalls?

A practical check is to request documentation for 2 or 3 products before committing to a larger order. Review the labels, batch details, expiry dates, and available quality records.

What Should You Check Before Finalising an Eye Drops Manufacturer?

The right manufacturing partner should meet regulatory requirements and provide clear commercial terms. A few checks before signing an agreement can prevent problems with product supply and distribution.

Use this checklist before making your decision:

  • Verify the manufacturing licence with the relevant authority.
  • Confirm that the specific products have the required permissions.
  • Review applicable GMP compliance and quality documentation.
  • Ask about batch testing and product release procedures.
  • Confirm minimum order quantities and delivery schedules.
  • Review monopoly rights and territory conditions in writing.
  • Understand product complaint and recall procedures.

For a new distributor, starting with a manageable order and monitoring product movement can provide a clearer picture of market demand.

Frequently Asked Questions About Eye Drops Manufacturers in India

1. How do I find a reliable eye drops manufacturer in India?

Check manufacturing licences, product permissions, GMP compliance, quality testing, product availability, and commercial terms. Request relevant documents before placing an order.

2. What is an ophthalmic PCD pharma franchise?

It is a pharmaceutical distribution arrangement in which a company authorises a distributor to market its ophthalmic products within an agreed territory under specified business conditions.

3. What are monopoly rights in an ophthalmic pharma franchise?

Monopoly rights provide agreed territorial exclusivity to a distributor. The geographical area, duration, renewal conditions, and other restrictions should be documented in the franchise agreement.

4. Can I start an ophthalmic pharma franchise with a small investment?

The investment depends on the company, product selection, minimum order quantity, territory, and promotional expenses. Request a written quotation to calculate your initial business cost.

5. What is third-party manufacturing of eye drops?

It is an arrangement in which a pharmaceutical business gets eye drops manufactured by an appropriately licensed third-party manufacturer under an agreed commercial and regulatory arrangement.

Final thoughts

Choosing the right Eye Drops Manufacturer in India requires careful evaluation of manufacturing quality, product permissions, documentation, pricing, and distribution support. Businesses exploring an ophthalmic PCD pharma franchise should also review monopoly rights and select products according to their target market.

A reliable manufacturing and distribution arrangement can give pharmaceutical entrepreneurs a practical starting point for building an ophthalmic medicine business in India.